Quantcast

Latest Melanoma Stories

2014-05-23 23:02:43

The June 2014 issue of Health Magazine offers a primer on protecting your skin from the sun’s harmful UV rays. Dr. Simon Ourian of Epione Medical Corporation comments on the magazine’s suggestions for properly applying sunscreen to each body part. Los Angeles, CA (PRWEB) May 23, 2014 According to the June 2014 issue of Health Magazine, as much as 90 percent of skin cancers, including deadly melanoma, can be traced directly to UV (Ultra Violet) exposure and that 20 percent of all...

2014-05-21 23:15:57

One year after the launch of DermUtopia, patients are learning how taking #selfies may save their life through early detection of skin cancer. Oak Hill, VA (PRWEB) May 21, 2014 This is a big month for the founders of DermUtopia, Dr. Brenda Dintiman and her daughter Christine Shanahan, who is currently completing her first year of medical school at the University of Virginia School of Medicine. May is #Melanoma Awareness Month and one year ago today, Dermutopia.com was launched to improve...

2014-05-21 23:14:34

Man invents antioxidant focused chemical free sunscreen to help prevent the return of his non-melanoma skin cancer. (PRWEB) May 21, 2014 Peter Zahner was frustrated with reoccurring bouts with non-melanoma skin cancer on his face, like actor Hugh Jackman just admitted to suffering from. His continued irritations, despite the use of brand name traditional sunscreen, led him to research and develop a non-toxic chemical free sunscreen called MelanSol®, now in its fifth generation. What...

Melanoma Drug From Pine Bark Substance
2014-05-21 10:20:43

By Matthew Solovey, Penn State A substance that comes from pine bark is a potential source for a new treatment of melanoma, according to Penn State College of Medicine researchers. Current melanoma drugs targeting single proteins can initially be effective, but resistance develops relatively quickly and the disease recurs. In those instances, resistance usually develops when the cancer cell's circuitry bypasses the protein that the drug acts on, or when the cell uses other pathways to...

2014-05-20 12:33:11

Convenes Policymaker Event, Highlights New Research, Organizes Social Media Push WASHINGTON, May 20, 2014 /PRNewswire/ -- In recognition that May is Skin Cancer Awareness Month, L'Oreal USA and the Public Access to SunScreens (PASS) Coalition sponsored a policy breakfast today focused on new innovations in sunscreen and legislation to establish a regulatory pathway for timely pre-market review of new, safe and effective over-the-counter sunscreen ingredients. The breakfast, which...

2014-05-15 08:32:30

First Case Study Announced While Broader Data Being Collected; Evidence Indicates Substantial Tumor Necrosis and Initial Tumor Regression BETHESDA, Md., May 15, 2014 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today provided an initial patient case study, showing signs of tumor necrosis (tumor death) and initial tumor regression, from the Company's ongoing...

2014-05-14 16:29:17

DecisionDx-Melanoma identifies patients with negative sentinel lymph node biopsies who are at high risk of metastasis FRIENDSWOOD, Texas, May 14, 2014 /PRNewswire/ -- Castle Biosciences Inc. announced today that abstracts reporting additional clinical validation data for two of its molecular tests -- one focused on melanoma and the other on esophageal adenocarcinoma -- will be presented at the 50(th) Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, May 30-June 3,...

2014-05-14 08:30:37

BOULDER, Colo., May 14, 2014 /PRNewswire/ -- Array BioPharma Inc. (NASDAQ: ARRY) today announced presentations on its MEK inhibitors, binimetinib (MEK162) (co-developing with Novartis) and selumetinib (licensed to AstraZeneca) at the 2014 American Society of Clinical Oncology (ASCO) Annual Meeting, which will be held May 30 - June 3, 2014 in Chicago, Illinois. Both MEK inhibitors are advancing in Phase 3 or pivotal trials: binimetinib is being evaluated in NRAS- and BRAF-mutant...

2014-05-13 23:09:20

Skin Cancer Awareness Month provides opportunities for dermatologists like Dr. Mitchel Goldman of Cosmetic Laser Dermatology to encourage patients to practice healthy skin care habits in order to prevent skin cancer. San Diego, CA (PRWEB) May 13, 2014 In a recent news segment, Dr. Mitchel Goldman, board-certified dermatologist and President of the American Society for Dermatologic Surgery (representing over 5,800 dermatologists in the USA), discussed the important facts surrounding Skin...

2014-05-13 08:31:13

NEW YORK, May 13, 2014 /PRNewswire/ -- Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT) is a development stage biopharmaceutical company that is primarily engaged in developing oncology and dermatology therapies through its two predominant drug candidates, PV-10 and PH-10. The company is working to develop PV-10 for the treatment of several life-threatening cancers, including metastatic melanoma, liver cancer (also known as Hepatocellular carcinoma, or HCC), and breast cancer....


Word of the Day
tesla
  • The unit of magnetic flux density in the International System of Units, equal to the magnitude of the magnetic field vector necessary to produce a force of one newton on a charge of one coulomb moving perpendicular to the direction of the magnetic field vector with a velocity of one meter per second. It is equivalent to one weber per square meter.
This word is named for Nikola Tesla, the inventor, engineer, and futurist.